News and analysis on diagnostic technologies and applications.
Qiagen's test detects the most frequently occurring somatic mutations in EGFR in less than four hours using real-time PCR on the Rotor-Gene Q platform.
Researchers showed that the test had equivalent results to a lab-based assay and has the potential for a faster turnaround time.
Despite initial promise, NGS-based MRD detection has not been broadly adopted, but improvements in technology and more clinical utility data may change that.
Its most advanced gene expression signatures are for infectious disease diagnostics and are aimed at enabling the appropriate prescription of antiviral and antibiotic medications.
Cosentyx is a human monoclonal antibody marketed by Novartis that is used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis.
